SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-019622
Filing Date
2024-05-01
Accepted
2024-05-01 16:17:56
Documents
79
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gthx-20240331.htm   iXBRL 10-Q 803361
2 EX-10.4 gthx-20240331xex104.htm EX-10.4 33894
3 EX-10.5 gthx-20240331xex105.htm EX-10.5 34400
4 EX-10.6 gthx-20240331xex106.htm EX-10.6 33949
5 EX-10.7 gthx-20240331xex107.htm EX-10.7 33391
6 EX-31.1 gthx-20240331xex311.htm EX-31.1 10846
7 EX-31.2 gthx-20240331xex312.htm EX-31.2 10911
8 EX-32.1 gthx-20240331xex321.htm EX-32.1 5618
9 EX-32.2 gthx-20240331xex322.htm EX-32.2 5682
15 gthx-20240331_g1.jpg GRAPHIC 8623
  Complete submission text file 0001628280-24-019622.txt   5704810

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gthx-20240331.xsd EX-101.SCH 43876
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gthx-20240331_cal.xml EX-101.CAL 52182
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gthx-20240331_def.xml EX-101.DEF 220863
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gthx-20240331_lab.xml EX-101.LAB 564416
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gthx-20240331_pre.xml EX-101.PRE 419056
82 EXTRACTED XBRL INSTANCE DOCUMENT gthx-20240331_htm.xml XML 613943
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38096 | Film No.: 24903278
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)